Examining the Impact of Real-World Evidence on Medical Product Development Proceedings of a Workshop Series (2019) / Chapter Skim
Currently Skimming:
Appendix B: Workshop One Agenda
Appendix B: Workshop One Agenda
Pages 183-190
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 183... ...
This first workshop will include discussions and background materials that address: • Aligning incentives and addressing barriers to support collection and use of real-world evidence in health product review, payment, and delivery. Workshops two and three will foster discussions that will: • Illuminate what types of data are appropriate for what specific purposes and suggest approaches for data collection that match the right data to the right questions.
|
From page 184... ...
Welcome and Opening Remarks Gregory Simon, Workshop Series Co-Chair Investigator Kaiser Permanente Washington Health Research Institute Keynote Address 8:30 a.m. Vision and Goals of a Collaborative, Practical, and Sustainable Real-World Evidence Program Scott Gottlieb Commissioner U.S.
|
From page 185... ...
Delivery System Perspective: Integrated Care Model at Kaiser Permanente Michael Horberg Executive Director, Research, Community Benefit, and Medicaid Strategy Executive Director, Mid-Atlantic Permanente Research Institute Kaiser Permanente Mid-Atlantic Permanente Medical Group 9:40 a.m. Delivery System Perspective: Academic Health System Daniel Ford Director, Institute for Clinical and Translational Research Johns Hopkins University School of Medicine 10:00 a.m.
|
From page 186... ...
Moderator: Gregory Simon, Kaiser Permanente Washington Health Research Institute 1:00 p.m. Generalizing and Scaling the Salford Lung Studies Martin Gibson Chief Executive Officer Northwest EHealth Marie Kane Chief Operating Officer Northwest EHealth 1:30 p.m.
|
From page 187... ...
Moderator: Petra Kaufmann, National Center for Advancing Translational Sciences, National Institutes of Health 3:20 p.m. Contract Research Organization Perspective John Doyle Senior Vice President and Managing Director QuintilesIMS
|
From page 188... ...
4:40 p.m. Discussion with Audience Additional Invited Discussants: Michael Horberg Executive Director, Research, Community Benefit, and Medicaid Strategy Executive Director, Mid-Atlantic Permanente Research Institute Kaiser Permanente Mid-Atlantic Permanente Medical Group Anna McCollister-Slipp Chief Advocate for Participatory Research, Scripps Translational Science Institute Founder, VitalCrowd Co-Founder, Galileo Analytics 5:30 p.m.
|
From page 189... ...
Recap Day 1 and Discussion with Workshop Participants Gregory Simon, Workshop Series Co-Chair Investigator Kaiser Permanente Washington Health Research Institute Keynote Address 9:00 a.m. False Precision and Estimating the Reliability of Effects with the Traditional Evidence-Generating Process Robert Califf Vice Chancellor, Health Data Science, Duke University Scientific Advisor, Verily Life Sciences Session IV: Getting Unstuck: Myth-Busting Session Objective: • Examine ideas -- and misconceptions -- about the necessity and acceptability of established evidence-generation practices.
|
From page 190... ...
Discussion with Audience Additional Invited Discussant: Deven McGraw Deputy Director, Health Information Privacy Office for Civil Rights U.S. Department of Health and Human Services 12:30 p.m.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.